FINWIRES · TerminalLIVE
FINWIRES

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $656,260, According to a Recent SEC Filing

By

-- Barry D Quart, Director, on April 28, 2026, sold 13,099 shares in Kiniksa Pharmaceuticals International (KNSA) for $656,260. Following the Form 4 filing with the SEC, Quart has control over a total of 12,546 Class A ordinary shares of the company, with 12,546 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000138424326000010/xslF345X05/form4-04292026_080403.xml

Related Articles